BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 24058181)

  • 1. Risk prediction of ventricular arrhythmias and myocardial function in Lamin A/C mutation positive subjects.
    Hasselberg NE; Edvardsen T; Petri H; Berge KE; Leren TP; Bundgaard H; Haugaa KH
    Europace; 2014 Apr; 16(4):563-71. PubMed ID: 24058181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late gadolinium enhanced cardiovascular magnetic resonance of lamin A/C gene mutation related dilated cardiomyopathy.
    Holmström M; Kivistö S; Heliö T; Jurkko R; Kaartinen M; Antila M; Reissell E; Kuusisto J; Kärkkäinen S; Peuhkurinen K; Koikkalainen J; Lötjönen J; Lauerma K
    J Cardiovasc Magn Reson; 2011 Jun; 13(1):30. PubMed ID: 21689390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanical dispersion assessed by myocardial strain in patients after myocardial infarction for risk prediction of ventricular arrhythmia.
    Haugaa KH; Smedsrud MK; Steen T; Kongsgaard E; Loennechen JP; Skjaerpe T; Voigt JU; Willems R; Smith G; Smiseth OA; Amlie JP; Edvardsen T
    JACC Cardiovasc Imaging; 2010 Mar; 3(3):247-56. PubMed ID: 20223421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac Mechanical Alterations and Genotype Specific Differences in Subjects With Long QT Syndrome.
    Leren IS; Hasselberg NE; Saberniak J; Håland TF; Kongsgård E; Smiseth OA; Edvardsen T; Haugaa KH
    JACC Cardiovasc Imaging; 2015 May; 8(5):501-510. PubMed ID: 25890583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mid-myocardial fibrosis by cardiac magnetic resonance in patients with lamin A/C cardiomyopathy: possible substrate for diastolic dysfunction.
    Raman SV; Sparks EA; Baker PM; McCarthy B; Wooley CF
    J Cardiovasc Magn Reson; 2007; 9(6):907-13. PubMed ID: 18066751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications.
    van Rijsingen IA; Bakker A; Azim D; Hermans-van Ast JF; van der Kooi AJ; van Tintelen JP; van den Berg MP; Christiaans I; Lekanne Dit Deprez RH; Wilde AA; Zwinderman AH; Meijers JC; Grootemaat AE; Nieuwland R; Pinto YM; Pinto-Sietsma SJ
    Int J Cardiol; 2013 Sep; 168(1):472-7. PubMed ID: 23073275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A novel lamin A/C mutation in a family with dilated cardiomyopathy and a strong history of sudden cardiac death].
    Andreassi MG; Botto N; Vittorini S; Pulignani S; Aquaro G; Sicari R
    Recenti Prog Med; 2010 Mar; 101(3):127-30. PubMed ID: 20461955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional differences in myocardial work of the left ventricle in patients with idiopathic dilated cardiomyopathy: Implications for the surgical technique used for left ventriculoplasty.
    Yanagida R; Sugawara M; Kawai A; Koyanagi H
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):600-7. PubMed ID: 11547316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
    Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise is Associated With Impaired Left Ventricular Systolic Function in Patients With Lamin A/C Genotype.
    Skjølsvik ET; Hasselberg NE; Dejgaard LA; Lie ØH; Andersen K; Holm T; Edvardsen T; Haugaa KH
    J Am Heart Assoc; 2020 Jan; 9(2):e012937. PubMed ID: 31957533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Arrhythmic and Nonarrhythmic Outcomes of Lamin A/C Mutation Carriers.
    Kumar S; Baldinger SH; Gandjbakhch E; Maury P; Sellal JM; Androulakis AF; Waintraub X; Charron P; Rollin A; Richard P; Stevenson WG; Macintyre CJ; Ho CY; Thompson T; Vohra JK; Kalman JM; Zeppenfeld K; Sacher F; Tedrow UB; Lakdawala NK
    J Am Coll Cardiol; 2016 Nov; 68(21):2299-2307. PubMed ID: 27884249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers.
    van Rijsingen IA; Nannenberg EA; Arbustini E; Elliott PM; Mogensen J; Hermans-van Ast JF; van der Kooi AJ; van Tintelen JP; van den Berg MP; Grasso M; Serio A; Jenkins S; Rowland C; Richard P; Wilde AA; Perrot A; Pankuweit S; Zwinderman AH; Charron P; Christiaans I; Pinto YM
    Eur J Heart Fail; 2013 Apr; 15(4):376-84. PubMed ID: 23183350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetralogy of Fallot: impact of the excursion of the interventricular septum on left ventricular systolic function and fibrosis after surgical repair.
    Muzzarelli S; Ordovas KG; Cannavale G; Meadows AK; Higgins CB
    Radiology; 2011 May; 259(2):375-83. PubMed ID: 21248236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal Pro brain natriuretic peptide is a reliable biomarker of reduced myocardial contractility in patients with lamin A/C gene mutations.
    Meune C; Wahbi K; Gobeaux C; Duboc D; Pecker F; Bonne G
    Int J Cardiol; 2011 Sep; 151(2):160-3. PubMed ID: 20627339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of myocardial fibrosis in patients with severe aortic valve stenosis.
    Milano AD; Faggian G; Dodonov M; Golia G; Tomezzoli A; Bortolotti U; Mazzucco A
    J Thorac Cardiovasc Surg; 2012 Oct; 144(4):830-7. PubMed ID: 22244555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired hyperemic myocardial blood flow is associated with inducibility of ventricular arrhythmia in ischemic cardiomyopathy.
    Rijnierse MT; de Haan S; Harms HJ; Robbers LF; Wu L; Danad I; Beek AM; Heymans MW; van Rossum AC; Lammertsma AA; Allaart CP; Knaapen P
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):20-30. PubMed ID: 24343851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.
    Fatkin D; MacRae C; Sasaki T; Wolff MR; Porcu M; Frenneaux M; Atherton J; Vidaillet HJ; Spudich S; De Girolami U; Seidman JG; Seidman C; Muntoni F; Müehle G; Johnson W; McDonough B
    N Engl J Med; 1999 Dec; 341(23):1715-24. PubMed ID: 10580070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Stratification of Genetic, Dilated Cardiomyopathies Associated With Neuromuscular Disorders: Role of Cardiac Imaging.
    van der Bijl P; Delgado V; Bootsma M; Bax JJ
    Circulation; 2018 Jun; 137(23):2514-2527. PubMed ID: 29866775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac involvement in patients with lamin A/C gene mutations: a cohort observation.
    Carboni N; Sardu C; Cocco E; Marrosu G; Manzi RC; Nissardi V; Isola F; Mateddu A; Solla E; Maioli MA; Oppo V; Piras R; Coghe G; Lai C; Marrosu MG
    Muscle Nerve; 2012 Aug; 46(2):187-92. PubMed ID: 22806367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study.
    Bloch Thomsen PE; Jons C; Raatikainen MJ; Moerch Joergensen R; Hartikainen J; Virtanen V; Boland J; Anttonen O; Gang UJ; Hoest N; Boersma LV; Platou ES; Becker D; Messier MD; Huikuri HV;
    Circulation; 2010 Sep; 122(13):1258-64. PubMed ID: 20837897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.